2020 | | Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma | 김보현, 김순선, 김재근, 이제희, 정재연, 조효정, 허지미 |
2020 | | Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment | 김보현, 김순선, 김재근, 은정우, 이제희, 정재연, 조효정, 허지미 |
2008 | | Living donor liver transplantation for Patients with beyond Milan hepatocellular carcinoma | 김명욱, 김봉완, 배병구, 배재익, 왕희정, 원제환 |
1997 | | Natural History of Chronic Hepatitis Type B throughout Long-term Follow-up | - |
2022 | | Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정 |
2021 | | Overexpressed proteins in hcc cell-derived exosomes, CCT8, and cofilin-1 are potential biomarkers for patients with HCC | 김순선, 은정우, 정재연, 조효정 |
2023 | | Quantitative Prediction of Posttransplant Hepatocellular Carcinoma Prognosis Using ADV Score: Validation with Korea-Nationwide Transplantation Registry Database | 김봉완 |
1998 | | Relationship of Serum Anti-p53 Antibody with p53 Expression in Liver Tissue of Chronic Liver Diseases | - |
2021 | | Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid–enhanced MRI in at-risk patients | 허지미 |
1998 | | Risk Factors and Treatment Strategy of Ruptured Hepatocellular Carcinoma | - |
2021 | | Risk factors for recurrence beyond Milan criteria after hepatic resection for hepatocellular carcinoma within Milan criteria | 김미나 |
2021 | | Role of immune cells in patients with hepatitis b virus‐related hepatocellular carcinoma | 정재연, 조효정 |
2010 | | Sarcomatoid hepatocellular carcinoma | 김영배, 석재연 |
2017 | | Second primary cancer after liver transplantation in hepatocellular carcinoma: a nationwide population-based study | 노오규, 오영택, 전미선, 허재성 |
2024 | | SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea | 김순선, 정재연, 조효정 |
2019 | | Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial | 정재연 |
2019 | | Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea | 김순선 |
2016 | | Surgical Strategy of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus | Mao, Wei |
2016 | | Surgical treatment for hepatocellular carcinoma with bile duct invasion | 김봉완, 왕희정, 홍성연 |
2019 | | The 7th/8th American Joint Committee on Cancer and the Modified Union for International Cancer Control Staging System for Hepatocellular Carcinoma | 김봉완, 왕희정, 홍성연 |
2021 | | Update on liver disease management during the pandemic of coronavirus disease 2019 (Covid-19): 2021 kasl guideline | 김순선 |
2021 | | Usefulness of cone-beam CT-based liver perfusion mapping for evaluating the response of hepatocellular carcinoma to conventional transarterial chemoembolization | 권요한 |